Legacy Wealth Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-2,501
Closed -$274K – 344
2023
Q4
$274K Sell
2,501
-10
-0.4% -$1.03K 0.09% 303
2023
Q3
$253K Sell
2,511
-51
-2% -$5.86K 0.09% 297
2023
Q2
$348K Sell
2,562
-76
-3% -$9.28K 0.12% 271
2023
Q1
$274K Sell
2,638
-1,380
-34% -$133K 0.1% 298
2022
Q4
$356K Sell
4,018
-1,823
-31% -$151K 0.14% 273
2022
Q3
$468K Sell
5,841
-92
-2% -$8.68K 0.2% 174
2022
Q2
$568K Buy
5,933
+153
+3% +$18.4K 0.23% 157
2022
Q1
$859K Buy
5,780
+266
+5% +$37.1K 0.31% 130
2021
Q4
$782K Buy
5,514
+201
+4% +$28.5K 0.26% 148
2021
Q3
$695K Buy
5,313
+8
+0.2% +$1.05K 0.32% 131
2021
Q2
$729K Sell
5,305
-408
-7% -$55.9K 0.32% 128
2021
Q1
$746K Buy
5,713
+102
+2% +$12.3K 0.34% 117
2020
Q4
$628K Buy
+5,611
New +$531K 0.32% 130

Other funds holding CNMD

Legacy Wealth Asset Management's CNMD Position: Q1 2024 in Review

Legacy Wealth Asset Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,501 shares — an estimated $274K sold.

Legacy Wealth Asset Management first reported a position in CNMD in Q4 2020 and held it in 13 quarters. The position peaked at $859K in Q1 2022. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Legacy Wealth Asset Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 2,501 CONMED shares in Q1 2024, an estimated $274K.
  • Legacy Wealth Asset Management first reported a position in CONMED in Q4 2020 and held it in 13 quarters.
  • Legacy Wealth Asset Management's CONMED position peaked at $859K in Q1 2022.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Legacy Wealth Asset Management's 13F filing for Q1 2024, filed 19 Apr 2024.